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A B S T R A C T
The objective of this article is to review the dramatic changes that have occurred in the ﬁeld of
epilepsy surgery since the founding of Epilepsy Action in 1950. We have chosen to consider these
advances from the biomedical perspective (the physician and basic scientist), and the behavioral
perspective (the psychologist and the patient). Both these viewpoints are equally important in
understanding the evolution of epilepsy surgery over the past 60 years, but may not always be well
synchronized.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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To put this review in historical perspective, the modern era of
surgical treatment for epilepsy was some 70 years old by the time
of the founding of Epilepsy Action, with initial seminal work
having been already performed in the United Kingdom.1 In 1879,
Macewen2 of Glasgow reported the ﬁrst resection of an
‘‘invisible’’ lesion to treat epilepsy based on localization derived
from the clinical seizure observations of John Hughlings Jackson,3
followed by a report on a series of cases in 1881.4 Five years later,
Victor Horsley published his seminal paper in Brain,5 combining
clinical–pathological correlations by Jackson3 and electrical
stimulation studies carried out on monkeys by Ferrier6 to
conﬁrm that localization of an epileptogenic region could be
determined by the signs and symptoms characterizing the onset
of the habitual clinical seizures. Using this approach, localization
was initially suspected by clinical observation of the seizure
onset, and conﬁrmed intraoperatively by identiﬁcation of a
structural abnormality, often accompanied by direct brain
stimulation.
Subsequent work in the early 20th century, particularly from
Germany7,8 and Canada9 further conﬁrmed the efﬁcacy of surgery
as a treatment for epilepsy, but these procedures were limited to a
small number of patients with focal seizures for whom a structural
lesion could be demonstrated. Use of lesion-directed surgery was* Corresponding author at: Psychological Sciences, The University of Melbourne,
Victoria 3010, Australia. Tel.: +61 3 8344 7391; fax: +61 3 9347 6618.
E-mail address: sarahw@unimelb.edu.au (S.J. Wilson).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.10.028greatly enhanced by development of pneumoencephalography in
191910 and cerebral angiography in 1934.11 Also at this time, a
revolutionary approach to monitoring both normal and abnormal
brain function was being developed.12,13 The electroencephalo-
gram (EEG) allowed patterns associated with epilepsy to be
recognized,14 and the ability of EEG interictal spikes to localize
epileptogenic tissue, including identiﬁcation of mesial temporal
structures as the site of onset of psychomotor seizures.15 Yet
despite EEG later playing a critical role in epilepsy surgery, by
1950 it played no role in the standard lesion-based approach to
epilepsy surgery. There were very few centers capable of
performing surgery as a treatment for epilepsy, and relatively
few patients underwent surgery at those centers; for many the
risks were high and the beneﬁts relatively low compared to
today’s practice.
2. The 1950s
2.1. The biomedical perspective
The decade following the founding of Epilepsy Action was a
period of seminal advances in understanding the patho-anatomical
basis of focal epilepsy and applying this information to surgical
treatment. Despite active research on EEG in epilepsy, epilepsy
surgery continued to be lesion-directed based predominantly on
evidence from angiography and pneumoencephalography of
structural brain abnormalities. This changed with the landmark
publication of Bailey and Gibbs (Figs. 1 and 2).16 Theywere the ﬁrst
to report a series of patients who underwent resection localized
exclusively by interictal EEG. These patients all had temporal lobevier Ltd. All rights reserved.
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Fig. 1. Percival Bailey (1892–1973).
[()TD$FIG]
Fig. 3. Wilder Penﬁeld (1891–1976) and Herbert H. Jasper (1906–1999).
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S.J. Wilson, J. Engel Jr. / Seizure 19 (2010) 659–668660resections for psychomotor seizures. A year earlier, Penﬁeld (Fig. 3)
and Flanigan17 had published a larger series of patients who
underwent temporal lobe resection for epilepsy based on lesion
identiﬁcation, and the following year Jasper et al.18 (Fig. 3)
published the complete EEG ﬁndings on these patients. These three
papers conﬁrmed that psychomotor seizures originated in the
temporal lobe, and that temporal lobe resectionswere beneﬁcial in
alleviating disabling seizures. As a result, there was a virtual
explosion of surgical activity worldwide, almost exclusively
focused on temporal lobe resections.1 Interestingly, these initial
resections were corticectomies for fear of possible deleterious
consequences from hippocampal removal, and only approximately
one-third of patients achieved seizure freedom. Surgical results
improved greatly once surgeons realized that mesial temporal
structures could be safely resected.19–21 It might be argued,
therefore, that initial results largely represented a placebo effect
and that temporal lobe surgery might never have been pursued
had it not been for this phenomenon.
The 1950s were also a time of rapid advances in diagnostic EEG,
particularly as applied to localization for surgery. Various
noninvasive approaches using nasopharyngeal, tympanic, and
sphenoidal electrodes were already in use by 1950, but direct
intraoperative EEG recording, electrocorticography (ECoG), was
felt to be most important for localization of the epileptogenic
region. Although Bickford and Kairns performed the ﬁrst chronic
depth electrode recordings by inserting multistranded insulated
wires into a cerebral bullet track at Oxford in 1944,22 the modern
approach to depth electrode recording was pioneered by Jean[()TD$FIG]
Fig. 2. Erma L. (1904–1988) and Frederick A. Gibbs (1903–1992).Talairach (Fig. 4) and Jean Bancaud (Fig. 5) in Paris in the late
1950s.23 The value of stereo EEG for three-dimensional localization
of epileptogenic tissue was rapidly appreciated; however, French
law at that time permitted electrodes to remain in place for only
several hours, so analysis was based on interictal spike activity, as
well as ictal discharges induced by electrical stimulation and
convulsant drugs.
An important contribution to research on the pathological
basis of temporal lobe epilepsy occurred in 1953.Murray Falconer
(Fig. 6) introduced a standardized en bloc anterior temporal
lobectomy procedure in London, which provided large intact
tissue specimens for pathological examination.24 As a result,
clinical pathological correlations revealed that a high percentage
of patients with temporal lobe epilepsy had hippocampal
sclerosis. This development was essential for later detailed
pathophysiological research on epileptogenic hippocampus,
and elucidation of the prognostic importance of hippocampal
sclerosis.Fig. 4. Jean Talairach (1911–2007).
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Fig. 7. Brenda Milner (1918–).
[()TD$FIG]
Fig. 5. Jean Bancaud (1921–1994).
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In the 1950s, the practice of epilepsy surgerywas not only being
advanced by signiﬁcant electrophysiological and patho-anatomi-
cal discoveries, but also by seminal contributions from those
committed to understanding brain–behavior relationships, such as
BrendaMilner (Fig. 7) and JuhnWada (Fig. 8). A striking illustration
is the now famous case of H.M., who in 1954 underwent a bilateral
temporal lobectomy for medically intractable seizures that
produced a dense postoperative amnesia.25 One year later, Milner
and Penﬁeld26 described impaired recent memory function after
unilateral temporal excision in the presence of bilateral mesial
temporal pathology, again involving the hippocampi. While H.M.
was not the ﬁrst case to undergo a bilateral procedure,27 Milner’s[()TD$FIG]
Fig. 6. Murray A. Falconer (1910–1977).systematic and scholarly evaluations of the surgical patients of
Penﬁeld and Scoville are widely recognized for identifying the
critical role of the mesial temporal region in recent memory
function.28 Herwork also demonstrated the important dissociation
between episodic and procedural memory, and gave rise to the
modern day material-speciﬁc model of episodic memory that
ascribed learning and retention of verbal material to the left
temporal lobe.29,30
Wilder Penﬁeld at the Montreal Neurological Institute (MNI)
ﬁrst promoted the use of a multidisciplinary approach, including
routine neuropsychological examination, for the surgical evalua-
tion of epilepsy patients.31 Pre-surgery, neuropsychology played
an increasing diagnostic role to (i) aid determination of the location
of cerebral abnormality, (ii) identify the risk for iatrogenic[()TD$FIG]
Fig. 8. Juhn Wada (1924–).
[()TD$FIG]
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(including intra-operative mapping), and (iii) assess the presence
of cortical reorganization of cognitive functions, notably right
hemisphere dominance for speech in left-handed patients.32
Relevant to this third issue, Juhn Wada pioneered the intracarotid
amobarbital procedure (also known as the ‘Wada test’) that
became themethod for determining hemispheric specialization for
speech and language functions pre-surgery.33,34 Introduction of
the technique to the MNI in 1955 demonstrated that early onset of
seizures was associated with greater prevalence of atypical
language organization, and it was subsequently used to assess
lateralized contributions of mesiotemporal structures to memory
function.35,36
Alongside these advances, Ward Halstead developed a battery
of neuropsychological measures that when applied to epilepsy
surgery, showed that surgery did not produce generalized
cognitive decline, and that post-operative improvement was
observable on some tasks.37 In London, Meyer and Yates also
reported minimal impact of temporal lobectomy on IQ scores, but
selectively identiﬁed the task of paired-associate learning as
having increased sensitivity to hippocampal dysfunction.38 Their
work supported the material-speciﬁc model of memory, and
distinguished recovery of language disturbance from auditory-
verbal learning impairments post-surgery. This was an important
precursor to contemporary theories of the role of the hippocampus
in ‘binding’ associations,30 and later identiﬁcation of arbitrary
relational learning as a neurocognitive marker of mesial temporal
epileptogenesis.39
From the patient’s perspective, epilepsy surgery is an elective
proceduremeaning that understanding its effects on cognition and
behavior are central to making an informed decision.40 In the
1950s, outcome studies initially measured the efﬁcacy of surgery
in terms of post-operative seizure frequency,16,17,19 however soon
after psychological functioning was considered mainly due to the
referral of patients from psychiatric sources and the then current
opinion associating temporal lobe epilepsy with psychological
problems.41,42 The results generally indicated that psychiatric
improvement followed seizure relief or improvement, despite a
time lag of 12–24 months between the two.43–46 During this
period, a transient worsening in patient mood or behavior could
occur, that Ferguson and Rayport47 attributed to a process of
psychological adjustment. This process stemmed from the
patient’s pre-operative psychosocial situation, where ‘illness’
behaviors and enmeshed family dynamics often engendered a
need for the patient to learn to become ‘well’ after surgery.47–49 In
recognition of this, Taylor (Fig. 9) spearheaded a series of studies in
[()TD$FIG]
Fig. 9. David C. Taylor (1933–).London that promoted a comprehensive review of patient change
pre- to post-surgery across a range of domains, including
psychological, psychiatric, family, socio-economic, and sexual
functioning.49–51
3. The latter part of the 20th century
3.1. The biomedical perspective
Bouchet and Cazauvieilh ﬁrst described hippocampal sclerosis
in the brains of patients with epilepsy in the early nineteenth
century,52 but by the 1960s it was still being debated whether this
was a result, or a cause, of epilepsy. Falconer’s en bloc temporal
resection made it possible to demonstrate that the presence of
hippocampal sclerosis predicted an excellent postoperative
outcome,46,53 indicating that this pathological abnormality was
epileptogenic. Not only was this conclusion ultimately important
for selection of surgical candidates and determining prognosis, it
identiﬁed brain tissue that would become valuable for basic
research into the fundamental mechanisms of epilepsy.
In 1963, Paul Crandall et al. (Fig. 10) at UCLA were the ﬁrst to
report the use of chronic stereotactically implanted depth
electrodes to record EEG changes occurring at the onset of
spontaneous seizures.54 Crandall then combined these chronic
electrophysiological recordings with Falconer’s standardized en
bloc anterior temporal resection, which permitted detailed
electroclinical–pathological correlations. This approach became
the basis for innovative multidisciplinary collaborative investiga-
tions into fundamental mechanisms of human epilepsy that are
now pursued at epilepsy surgery centers worldwide.55–57
At the same time, Ross Adey at UCLA was devising EEG
telemetry technology for the National Aeronautics and Space
Administration to record from chimpanzees orbiting the earth.58
Crandall and coworkers enlisted the collaboration of Adey to
develop the ﬁrst epilepsy EEG telemetry unit,59 which permitted
artifact-free continuous EEG recordings fromdepth electrodes over
long periods of time. During the 1970s, this advance was
accompanied by simultaneous cinemagraphic, and then video
monitoring, of ictal behavior, in order to obtain second-by-second
electroclinical correlations of ictal onset and propagation. Over
the next decade, EEG artifact rejection became sufﬁcientlyFig. 10. Paul Crandall (1923–).
Table 1
Outcomes before 1985 and from 1986 to 1990.
Number of patients (%)
Seizure-free Improved Not improved Total
Limbic resections
Before 1985 1296 (55.5) 648 (27.7) 392 (16.8) 2336 (100)
1986–1990 ATL 2429 (67.9) 860 (24.0) 290 (8.1) 3579 (100)
AH 284 (68.8) 92 (22.3) 37 (9.0) 413 (100)
Neocortical resections
Before 1985 356 (43.2) 229 (27.8) 240 (29.1) 825 (100)
1986–1990 ETR 363 (45.1) 283 (35.2) 159 (19.8) 805 (100)
L 195 (66.6) 63 (21.5) 35 (11.9) 293 (100)
Hemispherectomies
Before 1985 68 (77.3) 16 (18.2) 4 (4.5) 88 (100)
1986–1990 H 128 (67.4) 40 (21.1) 22 (11.6) 190 (100)
MR 75 (45.2) 59 (35.5) 32 (19.3) 166 (100)
Corpus callosotomies
Before 1985 10 (5.0) 140 (71.0) 47 (23.9) 197 (100)
1986–1990 43 (7.6) 343 (60.9) 177 (31.4) 563 (100)
ATL, anterior temporal lobectomy; AH, amygdalohippocampectomy; ETR, extra-
temporal resection; L, lesionectomy; H, hemispherectomy; MR, large multilobar
resection.
From Reference,113 with permission.
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scalp and sphenoidal electrodes.60,61
The advent of X-ray computed tomography (CT) in the 1970s
made it possible to visualize the entire brain in three dimensions,
to identify localized structural lesions in many patients with focal
epilepsy whose seizures had been diagnosed as cryptogenic.62 This
marked the beginning of modern neuroimaging, which has
gradually moved us back to a lesion-directed approach to epilepsy
surgery. Neuroimaging has not replaced EEG, however, which
remains essential for demonstrating that an identiﬁed lesion is
epileptogenic. With the later advent of magnetic resonance
imaging (MRI), which has higher resolution than CT, MRI rapidly
replaced CT for localizing structural lesions in epilepsy.
The next neuroimaging technique to play a critical role in
presurgical evaluation was functional, not structural. In the early
1980s, positron emission tomography (PET) with 18F-ﬂuorodox-
yglucose (FDG) revealed unilateral temporal hypometabolism in
patients with hippocampal sclerosis and other mesial temporal
lesions not visible on CT or MRI.60,63 Combining scalp and
sphenoidal video-EEG monitoring with FDG–PET and neuropsy-
chological testing obviated the need for invasive electrophysiolog-
ical investigations in many patients.60 Subsequently, FDG–PET
became useful in identifying large unilateral areas of cortical
dysplasia in infants and small children with secondary generalized
epilepsy64 who were candidates for hemispherectomy and multi-
lobar resections.
By 1990, improvement in MRI resolution permitted convincing
demonstration of hippocampal sclerosis,65 and is now able to
demonstrate cortical dysplasia66 and a variety of other subtle
lesions in patientswith epilepsywhowere previously diagnosed as
cryptogenic. Consequently, a signiﬁcant percentage of patients
who undergo surgery have hippocampal sclerosis and cortical
dysplasia that is identiﬁed noninvasively, many of whom might
not have been considered surgical candidates a decade or so
earlier. Additional PET tracers, such as ﬂumazenil (a benzodiaze-
pine receptor ligand), and a-methyl-tryptophane (AMT), have also
become useful in identifying potentially epileptogenic abnormali-
ties in patients with normal MRI.67
During this time, single photon emission computed tomography
(SPECT) was applied to reveal decreased cerebral perfusion in
epileptogenic temporal lobes but with a somewhat lower spatial
resolution than PET. SPECT became particularly useful, however,
when interictal hypoperfused regions became hyperperfused
ictally.68,69 Consequently, by the end of the 20th century, a variety
of functional and structural neuroimaging approaches had become
indispensable in presurgical evaluation. These technologies also
made it possible for neuroscientists interested in basicmechanisms
ofepilepsy tononinvasively identify theneuroanatomical substrates
of a variety of ictal behaviors and to begin to develop concepts of
neuronal networks underlying different epilepsy syndromes.
The last decade of the 20th century was a time of major
conceptual change in the practice of epilepsy surgery. In the 1980s,
most epilepsy surgery teams pursued only one particular surgical
approach, depending on where they were trained.1 The ﬁrst Palm
Desert Conference on Surgical Treatment of the Epilepsieswas held
in California in 1986, where virtually all of the epilepsy surgery
programs in the world at the time convened to compare strategies
and outcomes.70 Prior to this there had been only one textbook on
epilepsy surgery,71 and very few centers published their work, so
this was a novel opportunity for sharing experiences and
developing standardized approaches. Over the next ﬁve years
most epilepsy surgery programs tried approaches used at other
centers, and adopted different approaches for different types of
epilepsy. A follow-up Palm Desert conference in 1992 conﬁrmed
that most centers were now performing depth electrode and
subdural grid recordings selectively, operating on many patientsbased on noninvasive data, and carrying out a variety of surgical
procedures for different epilepsy conditions.72 During the inter-
vening six years there was also a tremendous increase in
publications on epilepsy surgery, a doubling of epilepsy surgery
centers worldwide, and improvement in seizure outcomes of
surgical treatment speciﬁcally for anterior temporal lobe resec-
tions (Table 1).
By the time of the second Palm Desert conference, the
tremendous increase in available antiepileptic drugs had become
an obstacle to timely surgical intervention because neurologists
could almost always ﬁnd another drug to try. In fact, the term
‘‘medically refractory epilepsy’’ lost its practical usefulness when it
would literally take a lifetime to try every available antiepileptic
drug in every conceivable combination in each individual patient.
A seminal conceptual advance introduced at the Palm Desert
conference, therefore, was the deﬁnition of surgically remediable
syndromes as conditions with a known etiology and a predictable
natural history of pharmacoresistance after failure of a few
appropriate antiepileptic drugs at maximal doses.73 Surgical
treatment for these conditions is cost-effective because presurgical
evaluation can usually be performed noninvasively and a high
percentage of patients, by deﬁnition, will become free of disabling
seizures postoperatively. Mesial temporal lobe epilepsy with or
without hippocampal sclerosis is the prototype of a surgically
remediable syndrome, but patients with demonstrable structural
lesions that can be surgically resected also have surgically
remediable epilepsy, as do infants and small children with
secondary generalized epilepsies due to diffuse structural lesions
limited to one hemisphere. It is important to note that many
patients with pharmacoresistant epilepsy who do not have a
surgically remediable epilepsy syndrome as deﬁned here, might
still beneﬁt from surgical treatment and could even become
seizure free. Such patients, however, usually require invasive
evaluation, and thus the risks are higher and the beneﬁts lower
than for patients with well-deﬁned surgically remediable epilepsy
syndromes. Reducing the risks and increasing the beneﬁts of
surgery for such patients remains a major challenge for the future.
3.2. The behavioral perspective
By the latter part of the 20th century, theWada test had become
a key tool in the neuropsychologist’s diagnostic armamentarium in
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methodological concerns arising in the late 1960s and early 1970s
about possible widespread diffusion of the barbituate, individual
differences in arterial distribution, imprecise determination of the
duration of maximal drug effect, and the use of different stimuli
and criteria for assessing language and memory across centers.
Initially progress to address these concerns was slow, likely
reﬂecting that the majority of clinicians using the Wada test had
been trained at, or followed the published protocols of one surgical
center.32 Although these concerns remain relevant today, by the
1990s considerable progress had been made, with work by Jones-
Gotman et al. at the MNI,74,75 and Loring and colleagues in
Georgia30 contributing to a range of studies focusing on the
reliability and validity of the procedure, accompanied by efforts to
deﬁne and standardize an optimal approach.76
In 1990, the National Institutes of Health (NIH) ‘Consensus
Conference on Surgery for Epilepsy’ declared neuropsychological
examination a necessary diagnostic procedure in the surgical
evaluation of epilepsy patients.77 The material-speciﬁc model had
become the cornerstone of the ﬁeld, guiding both presurgical
decision making and dominating the approach to the assessment
and interpretation of cognitive outcomes.39,40 Rausch and Babb at
UCLA had demonstrated that subﬁeld neuronal loss in the left
hippocampus speciﬁcally predicted impaired learning of arbitrari-
ly related words (the ‘hard’ pairs) of the paired-associate learning
task, but not semantically rich prose.78 Around the same time,
Saling et al. in Melbourne reported mildly impaired story recall in
patients with well characterised left or right mesial temporal foci,
but selectively impaired learning of arbitrarily related words in
patients with left mesial temporal foci.79 Notably, this led them to
consider task-speciﬁcity, rather than material-speciﬁcity, as the
more relevant factor in verbal memory outcomes, that distin-
guishes medial versus lateral specialization (or arbitrary versus
semantic forms of learning) within the temporal lobe.38
Consistent with this notion of task-speciﬁcity, Hermann et al.80
had reported that retroactive interference in word list learning
might provide the most ‘pure’ indicator of memory functioning of
the left temporal lobe, as it is unrelated to language adequacy.
Following this, Helmstaedter et al. showed thatmemory taskswith
a semantic component decline from pre-operative levels following
en bloc temporal resections, whereas this is not evident after
selective amygdalohippocampectomy. This provided further sup-
port for the notion of specialization of memory functions within
the temporal lobe, again fractionating the roles of mesial and
lateral temporal cortical structures.81
Perhaps most salient at the NIH Consensus Conference in 1990,
a new way of assessing surgical outcome was conceived ‘‘. . .that
would take advantage of validated and quantitative methods to
assess the quality of life and health status of individuals.’’77 This
was, in part, anticipated by Carl Dodrill’s work on quantifying the
psychosocial aspects of living with epilepsy through development
of the Washington Psychosocial Seizure Inventory.82 The health
related quality of life approach (HRQOL), however, extended this
work by utilizing a general measure, to allow comparison with
other chronic conditions, supplemented by epilepsy speciﬁc
items.77 While a large number of HRQOL measures have now
been established for people with epilepsy across cultures, Vickrey
et al. at UCLA ﬁrst responded to the NIH recommendation by
developing the Epilepsy Surgery Inventory-55,83 followed by a
measure established by Baker and coworkers in Liverpool.84,85
These subjective measures of quality of life were designed to
reﬂect the patient’s perception of daily functioning and experience
of health and well-being across a range of dimensions, including
general, physical, mental, and social functioning.
Initial studies employing HRQOL measures demonstrated that
improvements after surgery were linearly related to a reduction inseizure frequency.84,86 Soon after, the importance of other
predictors of post-operative HRQOL was recognized, including
mood (particularly depression), cognition (perceived memory),
employment, driving, and anticonvulsant cessation.87,88 In the case
of lowmood, a strong negative linear relationshipwith HRQOLwas
described by Gilliam et al.,89 likely reﬂecting that a sense of well-
being is a basic component of human existence maintained by
adaptive psychological processes that are essential for species
survival.90 Around the same time, work by Trimble and coworkers
in London,91 Blumer et al. in Memphis,92 and subsequently Wilson
and coworkers in Melbourne93 demonstrated the greater risk for
early mood disturbance following resection of the temporal lobe
compared to resection outside this region, including increased risk
for de novo depression.92,93 These ﬁndings support a broader,
emerging idea that shared pathogenic mechanisms may underpin
mesial temporal epileptogenesis and mood disturbance,94 and
possibly impaired episodic associative memory function.
While HRQOL research has principally focused on improve-
ments in well-being after surgery, by the last decade of the 20th
century progress had also been made in characterizing the nature
of the adjustment process reported by patients, particularly within
the ﬁrst 24 months after efﬁcacious surgery. Bladin and Wilson
likened this process to being ‘burdenedwith normality’, as patients
face new challenges and refashion their psychosocial milieu as
they undergo a psychological and social transition from chronically
ill to well.90,95 Characterization of this commonly reported
adjustment process concurred with an increasing emphasis in
the literature on the need for post-operative rehabilitation
programs that routinely address all aspects of a patient’s
functioning to maximize the ‘real life’ beneﬁts of seizure freedom
and decrease the signiﬁcant risk of adjustment difﬁculties and
mood disturbance post-surgery.96 In preparing patients for the
vicissitudes of post-operative life, the importance of addressing
pre-surgical expectations of both patients and family members
was also recognized,97,98 including the impact of expectations on
the patient’s view of the success of epilepsy surgery.99
4. The 21st century
The past decade has seen continued advances in diagnostic
testing and microsurgical techniques. This has increased the
accuracy of localization of the epileptogenic region and the safety
of surgery, as well as expanding the number of patients considered
surgical candidates to include thosewith nodemonstrated lesions
onMRI, or diffuse ormultifocal structural abnormalities, only one
of which might be responsible for generating habitual seizures.
Technologies that were still considered experimental at the
end of the 20th century have now become available for general
use, including magnetoencephalography (MEG), functional MRI
(fMRI), and simultaneous EEG–fMRI recordings with the capabili-
ty of localizing alterations in blood ﬂow associated with interictal
spikes and ictal EEG discharges. Additional useful approaches
include MR spectroscopy (MRS), to localize metabolic alterations
associatedwith the epileptogenic region, diffusion tensor imaging
(DTI) to map alterations in ﬁber tracks that may indicate the
presence of an epileptogenic lesion, and statistical parametric
mapping (SPM) of structural MRI, which provides high-resolution
deﬁnition of localized abnormalities that are not visible on
standard MRI.
fMRI now also provides a noninvasive means of mapping
essential neocortical functions, permitting the boundaries of
localized corticectomies adjacent to eloquent cortex to be
determined noninvasively prior to surgery. This has generally
been accompanied by a shift to validate less invasive techniques
for assessing language andmemory functions, using theWada test
as a benchmark. In conjunction with a worldwide shortage of
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for the Wada test.76 Recent surveys of a large number of epilepsy
surgery programs have indicated that the Wada test is no longer
routinely used in every patient. This has prompted a call for the
development of a set of guiding principles for use of the Wada, to
ensure the risk–beneﬁt ratio is justiﬁed.76
The epilepsy surgery setting has provided fertile ground for
basic scientists interested in understanding fundamental neuro-
nal mechanisms of epilepsy.100 For several decades, hippocampal
sclerosis has been the primary focus of attention, but in recent
years other common epileptogenic lesions, particularly focal
cortical dysplasia, have been the subject of investigation. Not
only is resected epileptogenic tissue available for molecular
biological, microanatomical, and electrophysiological in vitro
investigations, but several epilepsy centers have developed the
capability of chronic in vivo microelectrode techniques to record
localized ﬁeld potentials and single unit activity, as well as
microdialysis for evaluating neurotransmitter release. While the
ultimate objective of this research is to identify primary
epileptogenic abnormalities that could be the target for novel
pharmacotherapy and other treatments, it has also identiﬁed
disturbances that could lead to the development of reliable
biomarkers of epileptogenicity.
There is still no single diagnostic approach that can identify not
only the location but the extent of the epileptogenic region, that is
the area necessary and sufﬁcient for generation of spontaneous
seizures, and thus the minimal area that needs to be resected in
order to produce a seizure free outcome. The location and extent of
the epileptogenic region remains approximated based on a variety
of diagnostic information, including EEG, sophisticated neuroim-
aging, and neuropsychological testing, as well as observation
of seizure semiologies. The identiﬁcation of a biomarker that
would reliably localize uniquely to epileptogenic tissuewould be a
major advance for epilepsy surgery. Such a biomarker could
greatly decrease the cost and risk of presurgical evaluation,
improve surgical results, and increase the number of patients who
might be considered surgical candidates. Basic research in the
epilepsy surgery setting, along with parallel reiterative research
using experimental animal models of human surgically remedia-
ble epilepsy syndromes, have revealed a number of disturbances
that could become targets for effective biomarkers (Table 2).
At present, there are two potential biomarkers under active
investigation.
There is evidence that AMT, on PET, localizes to epileptogenic
tissue, particularly when there are multiple potential epileptogen-
ic lesions, as in the case of tuberous sclerosis.101 More recent
interest, however, has been in pathological high-frequency
oscillations (pHFOs), brief 100–600 Hz EEG events often associated
with interictal spikes which are believed to be summated action
potentials of the synchronously bursting neurons characteristic of
epileptogenic tissue.102 Although reports from several centers
suggest that pHFOs could more reliably identify epileptogenic
tissue than interictal EEG spikes and even ictal onset,103 these
events can only be recorded from electrodes within or on theTable 2
Target mechanisms for biomarkers of epileptogenicity and epileptogenesis.
Cell loss
Axonal sprouting
Synaptic reorganization
Altered neuronal function (gene expression proﬁles, protein products)
Neurogenesis
Altered glial function and gliosis
Inﬂammatory changes
Angiogenesis
Altered excitability and synchronysurface of the brain. To be most useful, noninvasive approaches to
recording pHFOs are needed, and perhaps will be provided byMEG
or EEG–fMRI. If the accuracy of these putative biomarkers is
conﬁrmed, even when invasive recording is required this could
greatly reduce the cost and increase the efﬁcacy of resective
surgical treatment. As pHFOs are frequent interictal events, the
invasive recording could be completed in a few hours, without the
need for long-term chronic recording to capture spontaneous
seizures.
The concept of identifying new markers of outcome has also
emerged in current behavioral research.40 Moving away from the
material-speciﬁc model, neurocognitive markers of mesial tempo-
ral dysfunction have been proposed, with arbitrary relational
learning providing a candidate endophenotype of disruption of the
rhinal–hippocampal interface.39 Progress has also been made in
identifying neurobiological and psychological markers of risk for
mood disturbance after surgery,104,105 with reduced contralateral
hippocampal volume pre-surgery recently being identiﬁed as a
marker for increased risk of depression post-surgery.106 This
approach requires an understanding of the complex interaction of
biological, cognitive, psychological, and social factors at play in a
given individual, that combined, create the framework for an
individual’s trajectory from seizure onset to chronicity and
subsequent response to surgical treatment. For example, prelimi-
nary work linking the process of post-operative adjustment with
HRQOL outcomes indicates that patients with early onset of
seizures (before or during adolescence) are more likely to
experience a greater sense of self-change after surgery, that while
tumultuous, ultimately concurs more beneﬁcial effects for
HRQOL.107 In contrast, work linking HRQOL with cognitive
outcomes shows that the ‘‘double whammy’’ of seizure recurrence
and memory decline has a highly detrimental effect on HRQOL.108
Greater understanding of these interactions and their individual
differences lies at the heart of identifying markers of risk for, and
resilience to, poor post-operative outcomes. This is directly
relevant to the ongoing development of models of post-surgical
rehabilitation that can target treatment interventions to an
individual’s speciﬁc phase and needs in post-operative recovery,
to facilitate improvements in day-to-day functioning over the
long-term.
Access to epilepsy surgery remains a major obstacle to be
overcome. Epilepsy surgery is arguably the most underutilized of
all therapeutic approaches that are generally accepted as effective.
Perhaps only 1% of potential surgical candidates are ever referred
to an epilepsy surgery center in industrialized countries, and at the
beginning of this century very few individuals with epilepsy living
in the developing world had access to surgical treatment. Several
important advances have been made in the past decade in an
attempt to improve this situation. Reluctance on the part of
physicians and patients to consider surgical intervention has been
attributed to several factors. Fear of surgery is understandable,
although the risk of morbidity and mortality is much greater with
uncontrolled disabling seizures than it is with surgery. We
obviously have not done as good a job as we could in educating
the general public and the medical community, despite the
signiﬁcant increase in publications since the ﬁrst Palm Desert
conference, that all support the safety and efﬁcacy of surgical
treatment for epilepsy.
One criticism at the end of the last century was that there had
never been a randomized controlled trial (RCT) of epilepsy surgery
that clearly conﬁrmed the safety and efﬁcacy that is reported in
published uncontrolled series. This concern was overcome in 2001
with the publication of a RCT of epilepsy surgery at the University
of Western Ontario109 that clearly demonstrated the superiority of
surgical treatment over continued pharmacotherapy in patients
with temporal lobe epilepsy. Based on this, in 2003, the American
S.J. Wilson, J. Engel Jr. / Seizure 19 (2010) 659–668666Academy of Neurology, in association with the American Epilepsy
Society and the American Association of Neurological Surgeons,
published a practice parameter based on the RCT and a
metanalysis, declaring surgical therapy the treatment of choice
for pharmacoresistant temporal lobe epilepsy.110 Interestingly,
two-thirds of patients were seizure free in the RCT and also in the
metanalysis, indicating that the results of uncontrolled series are
reliable. Nevertheless, a similar recommendation was not permit-
ted for corticectomies based on metanalysis because no RCT had
been performed.
The practice parameter also recommended that surgical
treatment be carried out in a timely fashion in order to avoid
the development of irreversible psychological and social con-
sequences of disabling epileptic seizures. That same year, results of
a multicenter study indicated that the average interval from onset
of epilepsy to referral for surgery at seven centers in the United
States was 22 years.111 An encouraging development over the past
decade resulting from improvement in presurgical diagnostic
approaches, has been the establishment of highly successful
epilepsy surgery programs in emerging countries of Latin America,
Asia, and the eastern Mediterranean. Recently, however, a study at
UCLA revealed that the RCT and practice parameter has had no
effect on the timing of surgical referral, which was exactly the
same over two four-year periods taken in the 1990s, and towards
the end of the current decade.112 Considerable work is ongoing to
make epilepsy surgery safer, cheaper, and more effective, and
tremendous advances have occurred in the 60 years since the
founding of Epilepsy Action. Clearly a major effort is needed to
communicate these advances to the general public and medical
community in order to address the unacceptable treatment gap
between potential surgical candidates and actual surgical treat-
ment worldwide. In this regard, Epilepsy Action and the journal
Seizure continue to play a vital role.
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